Channel June 2, 2016 Leveraging Scorecard Analytics to Optimize Changes to DSAs 2 Minute Read In my last post, I explored how IntegriChain Scorecard Analytics can be used to validate whether the implementation of Distribution Service Agreements (DSAs) drives channel performance. In this post, we will...
Patient Access May 27, 2016 Trends in Specialty Pharmacy Channel Design – Takeaways from Asembia Specialty... 3 Minute Read The Asembia (formerly known as Armada) Specialty Pharmacy Summit is fast becoming the pharmaceutical industry’s most important meeting. This year’s Las Vegas show boasted a record attendance of nearly...
Channel April 6, 2016 IntegriChain Continues to Lead in Automated, End-to-End Management of Pharma Distribution... 2 Minute Read Distribution Service Agreements (DSAs) have continued to evolve over recent years especially as they relate to how they evaluate channel performance. For the most part, manufacturers structure the agreements...
Channel March 2, 2016 867 Master Data and Channel Analytics Has Emerged as the Best... 2 Minute Read By now, government price departments are well underway towards implementing the Final Average Manufacturer Price (AMP) Rule recently issued by the Center of Medicare and Medicaid Services (CMS). AMP...
Corporate March 1, 2016 IntegriChain and Accel-KKR Share Vision for Serving Evolving Channel Analytic Needs... 1 Minute Read Today we announced an equity partnership with Accel-KKR (AKKR) that is very exciting both for IntegriChain and our customers. Both IntegriChain and AKKR share a singular vision to service...
Access Transformation December 2, 2015 Renewed Emphasis on Driving the Retail Pharmacy Channel 4 Minute Read You might have noticed that we recently announced the release of a new set of channel visualizations focused on the retail pharmacy. In an era when specialty pharmacy so...
Corporate October 27, 2015 IntegriChain Launches New Hybrid Cloud 1 Minute Read We have partnered with Amazon Web Services (AWS) and have big plans to leverage the fastest growing cloud platform on the planet. The rate of growth and innovation...
Contracts & Pricing July 9, 2015 GAO 340B Report: The Debate on Whether 340B Financial Incentives Create... 2 Minute Read For those of us who monitor the 340B Drug Pricing Program, a fascinating report and industry debate erupted this week over the June 2015 US Government Accountability Office (GAO)...
Contracts & Pricing June 15, 2015 Master Data Management is an Essential Building Block for Manufacturers Seeking... 2 Minute Read The 340B program has been on the minds of many pharmaceutical, healthcare, public policy, and legal stakeholders of late. Regardless of how the so-called “mega-rule” evolves, most drug manufacturers...
